Drug postmarketing studies - Reply

Kevin Fain; G. Caleb Alexander

doi:10.1001/jama.2013.278904

Drug postmarketing studies - Reply

Bloomberg School of Public Health

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2459-2460
Number of pages	2
Journal	JAMA
Volume	310
Issue number	22
DOIs	https://doi.org/10.1001/jama.2013.278904
State	Published - Dec 11 2013

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1001/jama.2013.278904

Cite this

@article{bbd07abc19384eb383df3c3d0d4a4a08,

title = "Drug postmarketing studies - Reply",

author = "Kevin Fain and Alexander, {G. Caleb}",

year = "2013",

month = dec,

day = "11",

doi = "10.1001/jama.2013.278904",

language = "English (US)",

volume = "310",

pages = "2459--2460",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "22",

}

TY - JOUR

T1 - Drug postmarketing studies - Reply

AU - Fain, Kevin

AU - Alexander, G. Caleb

PY - 2013/12/11

Y1 - 2013/12/11

UR - http://www.scopus.com/inward/record.url?scp=84889858063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889858063&partnerID=8YFLogxK

U2 - 10.1001/jama.2013.278904

DO - 10.1001/jama.2013.278904

M3 - Letter

C2 - 24327045

AN - SCOPUS:84889858063

VL - 310

SP - 2459

EP - 2460

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 22

ER -

Drug postmarketing studies - Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this